GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » Equity-to-Asset

TVGN (Tevogen Bio Holdings) Equity-to-Asset : -1.44 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Tevogen Bio Holdings's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-6.19 Mil. Tevogen Bio Holdings's Total Assets for the quarter that ended in Sep. 2024 was $4.29 Mil.

The historical rank and industry rank for Tevogen Bio Holdings's Equity-to-Asset or its related term are showing as below:

TVGN' s Equity-to-Asset Range Over the Past 10 Years
Min: -15.41   Med: -1.73   Max: 0.96
Current: -1.44

During the past 3 years, the highest Equity to Asset Ratio of Tevogen Bio Holdings was 0.96. The lowest was -15.41. And the median was -1.73.

TVGN's Equity-to-Asset is ranked worse than
92.61% of 1503 companies
in the Biotechnology industry
Industry Median: 0.67 vs TVGN: -1.44

Tevogen Bio Holdings Equity-to-Asset Historical Data

The historical data trend for Tevogen Bio Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Equity-to-Asset Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23
Equity-to-Asset
-2.15 0.96 -0.04

Tevogen Bio Holdings Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.04 -1.73 -2.31 -1.44

Competitive Comparison of Tevogen Bio Holdings's Equity-to-Asset

For the Biotechnology subindustry, Tevogen Bio Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tevogen Bio Holdings's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Tevogen Bio Holdings's Equity-to-Asset falls into.


;
;

Tevogen Bio Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Tevogen Bio Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=-0.696/17.037
=

Tevogen Bio Holdings's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=-6.19/4.289
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tevogen Bio Holdings  (NAS:TVGN) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Tevogen Bio Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

From GuruFocus